Greatbatch Completes Nuvectra Spin-Off

Greatbatch has completed the spin-off of QiG Group, which previously changed its name to Nuvectra.

Under a long-term supply agreement, Greatbatch will manufacture Nuvectra’s first implantable device, the Algovita spinal cord stimulation system, which is approved in the U.S and Europe.

Nuvectra will focus on neurostimulation technology.

“This spin-off reaffirms Greatbatch’s commitment to ensuring its strategic priorities remain aligned with stockholders’ best interests while continuing to create enhanced value for customers, healthcare providers and other key stakeholders,” said Thomas Hook, president and CEO at Greatbatch. — Anisa Jibrell